The University of Pennsylvania School of Veterinary Medicine or Penn Vet is making revolutionary strides in the fight against canine cancer. Penn Vet Assistant Professor Dr. Nicola Mason, VBetMed, PhD, DACVIM, who has studied cancer and immunotherapy for more than 15 years, has found a marked similarity in tumors between dogs and humans.
Sixty percent of dogs with osteosarcoma, an aggressive bone cancer, die within one year of diagnosis. But thanks to Dr. Nicola's groundbreaking cancer immunotherapy trials, the overall survival of dogs suffering with this devastating disease has been prolonged. The results of these clinical trials offer hope to humans with cancer, including children with osteosarcoma and women with breast cancer.
Dr. Mason is currently recruiting patients for a new trial for dogs with early osteosarcoma that have not undergone limb amputation. Pet owners interested in enrolling a dog in this study should contact Dr. Mason at nmason@vet.upenn.edu or 215-898-3996. Eligibility and trial details can be found here.
DON'T FORGET TO STOP BY BRAXTON'S TO CHECK OUT OUR WINTER GEAR!